Mosquito-Borne Virus Discovery, Diagnostics and Vaccines
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Insect Viruses".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 821
Special Issue Editors
2. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo 690-8504, Japan
Interests: dengue virus; zika virus; chikungunya virus; serology; molecular epidemiology
Special Issues, Collections and Topics in MDPI journals
Interests: Japanese encephalitis virus; O Nyong Nyong virus; mayaro virus; getah virus; dengue virus; pathogenesis; molecular epidemiology
Special Issue Information
Dear Colleagues,
Mosquito-borne viral diseases have dramatically increased and become challenges for public health systems around the world. Rising urbanization, global travel, climate change and global warming and the migration of populations have expanded the potential for mosquitoes to proliferate, hence causing disease on a wider scale. Mosquito-borne viral diseases are a group of viral illnesses predominantly transmitted by mosquitoes, including viruses from the Flaviviridae and Togaviridae families, which are the most important arboviruses that cause diseases in humans. This trend has raised significant concerns for public health. Despite decades of research, there are currently no approved antiviral drugs or safe and effective vaccines for the prevention and treatment of flavivirus and alphavirus infection. Hence, it is urgent to understand and determine viral- and host-enhancing mosquito-borne viral diseases to develop vaccines and encourage antiviral drug discovery.
In this Special Issue, we will gather a collection of research papers and reviews considering serological aspects, molecular diagnosis approaches for treating mosquito-borne viral diseases including flaviviruses, such as DENV (Dengue virus), JEV (Japanese encephalitis virus), ZIKV (Zika virus), YFV (Yellow Fever virus), WNV (West Nile virus) and alphaviruses, such CHIKV (Chikungunya irus), ONNV (O Nyong Nyong virus), SINV (Sinbis virus), SFV (Semliki Forest virus) and RRV (Ross River Virus), as well as virus–host interactions and viral pathogenesis in animal models, to promote the discovery of antiviral drugs discovery and vaccine development. We look forward to receiving your submissions.
Dr. Mya Myat Ngwe Tun
Dr. Basu Dev Pandey
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mosquito-borne viruses
- diagnostic approach
- serology
- molecular epidemiology
- pathogenesis
- antiviral drug
- vaccine development
- vitro assay
- vivo assay (animal model)
